Clinical Trials Browser

Phase 1/2 × Glioblastoma × anlotinib × Clear all

NCT04004975 2019-07-02

Clinical Study on the Treatment of Recurrent Glioblastoma With Anlotinib

Phase 1/2 Unknown

Glioblastoma